Amicus Therapeutics (FOLD) Research & Development (2016 - 2025)
Historic Research & Development for Amicus Therapeutics (FOLD) over the last 17 years, with Q3 2025 value amounting to $23.4 million.
- Amicus Therapeutics' Research & Development fell 1049.31% to $23.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.3 million, marking a year-over-year increase of 2459.79%. This contributed to the annual value of $109.4 million for FY2024, which is 2823.12% down from last year.
- As of Q3 2025, Amicus Therapeutics' Research & Development stood at $23.4 million, which was down 1049.31% from $60.8 million recorded in Q2 2025.
- Amicus Therapeutics' Research & Development's 5-year high stood at $85.6 million during Q4 2021, with a 5-year trough of $23.4 million in Q3 2025.
- For the 5-year period, Amicus Therapeutics' Research & Development averaged around $48.6 million, with its median value being $41.5 million (2023).
- Per our database at Business Quant, Amicus Therapeutics' Research & Development tumbled by 5512.07% in 2023 and then surged by 14651.78% in 2025.
- Quarter analysis of 5 years shows Amicus Therapeutics' Research & Development stood at $85.6 million in 2021, then fell by 25.38% to $63.9 million in 2022, then tumbled by 45.16% to $35.0 million in 2023, then decreased by 13.81% to $30.2 million in 2024, then fell by 22.44% to $23.4 million in 2025.
- Its last three reported values are $23.4 million in Q3 2025, $60.8 million for Q2 2025, and $27.8 million during Q1 2025.